全球 H1N1（猪流感）疫苗市场 – 行业趋势及 2030 年预测

H1N1（猪流感）疫苗市场分析及规模

H1N1 流感，有时也称为猪流感，是一种甲型流感病毒。它通常被称为猪流感，是一种感染猪、鸟和人类的新型流感病毒组合。最近出现了严重的流感病例。根据世界卫生组织 (WHO) 的数据，每年约有 300 万至 500 万例重症病例和约 29 万至 65 万例呼吸道死亡病例是由季节性流感引起的。此外，由于老年人口增加，呼吸道疾病和免疫缺陷疾病的发病率不断上升，这进一步为 H1N1（猪流感）疫苗市场带来了巨大的增长机会。

Data Bridge Market Research 分析，H1N1（猪流感）疫苗市场规模将在 2022 年达到 132.9 亿美元，到 2030 年将增至 215.1 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 6.20%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

H1N1（猪流感）疫苗市场范围和细分

Market Definition

The H1N1 virus mainly causes swine flu. The H1N1 virus impedes the functioning of respiratory organs, which includes the nose, lungs, and throat. The H1N1 virus is a ribonucleic acid (RNA) virus belonging to the orthomyxoviridae family. The virus leads to high fever, body fatigue, headache, red, watery eyes, and general discomfort. The H1N1 virus also affects swine, birds, horses, and other animals apart from humans. The virus is transmissible and can spread from human to human.

Global H1N1 (Swine Flu) Vaccination Market Dynamics

Drivers

• Increasing Prevalence of Flu

Worldwide, the prevalence of flu is 3 to 5 million cases of severe illness and around 290, 000 to 650, 000 respiratory deaths. As per the Centers for Disease Control (CDC), around 8 percent of the U.S. population gets sick from the flu. In addition to this, around 200,000 people end up in the hospital every flu season. Thus, this increasing prevalence leads to the higher adoption of swine flu vaccination. This factor leads to the growth of the market.

• Growing Demand for Intramuscular Vaccines

There is a higher demand for intramuscular vaccines, which lead to market growth. The intramuscular vaccines segment holds a significant market share in the H1N1 vaccines market and is expected to show a trend during the forecast period. Increasing incidences of swine flu and the need for H1N1 vaccination is growing, and as a result, the intramuscular vaccines segment is also growing. Thus, this factor help in the market growth.

Opportunities

• Increasing Awareness of New Technologies in Vaccination

Numerous new technologies have the potential to alter the response activities of drugs in patients. These technologies involve the use of high-throughput approaches and whole-genome next-generation sequencing. These approaches can not only boost a new surveillance paradigm but also become major elements that are to be used in outbreak investigations. Developing techniques and approaches such as synthetic genomics, systems genetics, mathematical modeling, and systems biology are highly helpful. Thus, this factor boosts the market growth.  

• Increasing Rate of Elderly Population

Another major factor boosting market growth is declining immunity among the geriatric population. The increasing elderly population with weakened immune systems makes them vulnerable to swine flu infection at a higher rate. Although H1N1 flu can affect anyone, immunocompromised people, such as cancer patients, are more vulnerable to swine flu and other infections. According to UN.org, the population above the age of 65 was around 703 million in 2019 and will double to around 1.5 billion by 2050 globally. Thus, this factor serves as a major factor that increases market growth.

Restraints/Challenges

• Side-Effects of H1N1 (swine flu) vaccination

Numerous effects are associated with H1N1 (swine flu) vaccination products. Local effects such as discomfort and local swelling at the vaccination site, reduced appetite and activity, sneezing, mild fever, "snotty nose," and mild coughing. Thus, this factor impedes market growth.  

• Lack of Skilled Medical Individuals

There is a lack of skilled healthcare professionals that fail to deal with these patients who attain swine flu. Many of the viral diseases mimic each other and there is a very thin line of differentiation. Professionals fail to identify the diseases and sometimes lack a proper treatment. Thus, this factor leads to the market hindrance.

This H1N1 (swine flu) vaccination market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the H1N1 (swine flu) vaccination market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global H1N1 (Swine Flu) Vaccination Market Scope

The H1N1 (swine flu) vaccination market is segmented on the basis of vaccine type, type of brand, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Vaccine Type

• Intranasal
• Conjugate
• Attenuated Vaccines
• Inactivated Vaccines
• Intramuscular
• Toxoid

Type of Brand

• Agripal
• Fiuarix
• Influgen
• Influvac
• Nasovac
• Vaxigrip
• Others

End User

• Hospitals
• Clinics
• Others

H1N1 (Swine Flu) Vaccination Market Regional Analysis/Insights

The H1N1 (swine flu) vaccination market is analyzed and market size insights and trends are provided by vaccine type, type of brand, end user as referenced above.

H1N1（猪流感）疫苗市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

预计亚太地区 H1N1（猪流感）疫苗市场将在预测期内增长，因为人们对该病毒的认识不断提高，感染人数不断增加。此外，该地区发达的医疗保健基础设施也推动了市场增长。

在预测期内，北美由于研发支出增加而占据市场主导地位。此外，各国政府正在采取多项举措，通过各种计划、疫苗接种活动和检测试剂盒来避免疾病在人群中传播，从而推动市场增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

H1N1（猪流感）疫苗市场还为您提供了每个国家/地区资本设备医疗保健支出增长情况的详细市场分析、H1N1（猪流感）疫苗市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对 H1N1（猪流感）疫苗市场的影响。数据涵盖 2011-2021 年的历史时期。

竞争格局和 H1N1（猪流感）疫苗市场份额分析

H1N1（猪流感）疫苗市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对 H1N1（猪流感）疫苗市场的关注有关。

H1N1（猪流感）疫苗市场的一些主要参与者包括：

• 赛诺菲（法国）
• 辉瑞公司（美国）
• 葛兰素史克公司 (英国)
• 诺华公司（瑞士）
• Mylan NV（美国）
• 百特（美国）
• 阿斯利康（英国）
• 强生私人有限公司（美国）
• 维克（法国）
• Vetoquinol（法国）
• 硕腾 (美国)
• Novavax（美国）。
• Zydus 集团（印度）。
• Panacea Biotec（印度）。
• 科兴（中国）。
• 雅培（美国）
• SEQIRUS（美国）
• Cipla Inc（印度）

SKU-23970